Technical Analysis for APLI - Appili Therapeutics Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 0.035 | 16.67% | 0.005 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Bullish Engulfing | Bullish | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Reversed from Up | 1 day ago |
| 200 DMA Resistance | 1 day ago |
| 50 DMA Resistance | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Rose Above 50 DMA | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 2024-11-11
Appili Therapeutics Inc Description
Appili Therapeutics Inc is a Canada-based anti-infective pharmaceutical development company. The Company focuses on identifying, acquiring and advancing therapeutics for infectious disease. The Company is engaged in developing strategies to develop new classes of antibiotics and anti-infectives to the clinic to improve treatment and health of patients suffering from infection. The Company has over two anti-infective programs, which include ATI-1501 and ATI-1503. The Company's ATI-1501 is a taste-masked treatment for clostridium difficile infection. The Company's ATI-1503 is an antibiotic with a potential to treat Gram-negative infections, such as Klebsiella pneumoniae. The Company’s agents focus on the therapeutics, including antivirals, antifungals, antiparasitics and antimicrobials, which can treat the hospital and community acquired infections caused by multi-drug resistant pathogens.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Disease Bacteria Infection Antimicrobial Anti Infectives Antibiotic Organisms Antibiotics Antivirals Biocides Infections Infectious Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.08 |
| 52 Week Low | 0.025 |
| Average Volume | 122,505 |
| 200-Day Moving Average | 0.035 |
| 50-Day Moving Average | 0.034 |
| 20-Day Moving Average | 0.037 |
| 10-Day Moving Average | 0.036 |
| Average True Range | 0.003 |
| RSI (14) | 49.75 |
| ADX | 21.57 |
| +DI | 33.787 |
| -DI | 35.374 |
| Chandelier Exit (Long, 3 ATRs) | 0.035 |
| Chandelier Exit (Short, 3 ATRs) | 0.040 |
| Upper Bollinger Bands | 0.042 |
| Lower Bollinger Band | 0.031 |
| Percent B (%b) | 0.37 |
| BandWidth | 30.685 |
| MACD Line | 0.000 |
| MACD Signal Line | 0.001 |
| MACD Histogram | -0.0006 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.043 | ||||
| Resistance 3 (R3) | 0.042 | 0.038 | 0.041 | ||
| Resistance 2 (R2) | 0.038 | 0.036 | 0.039 | 0.041 | |
| Resistance 1 (R1) | 0.037 | 0.035 | 0.038 | 0.038 | 0.040 |
| Pivot Point | 0.033 | 0.033 | 0.034 | 0.034 | 0.033 |
| Support 1 (S1) | 0.032 | 0.031 | 0.033 | 0.033 | 0.030 |
| Support 2 (S2) | 0.028 | 0.030 | 0.029 | 0.029 | |
| Support 3 (S3) | 0.027 | 0.028 | 0.029 | ||
| Support 4 (S4) | 0.028 |
